Literature DB >> 7004535

Immunofluorescent identification of human megakaryocyte colonies using an antiplatelet glycoprotein antiserum.

E M Mazur, R Hoffman, J Chasis, S Marchesi, E Bruno.   

Abstract

The development of a satisfactory in vitro assay system for human megakaryocyte colony forming progenitor cells has been delayed by the lack of a suitable marker for cells of human megakaryocyte lineage. For this purpose we raised an antiserum directed against a purified human platelet glycoprotein preparation. In conjunction with indirect immunofluorescent staining of human bone marrow, this antiserum labeled only platelets, megakaryocytes, and an infrequent population of small mononuclear cells. These small mononuclear cells, not otherwise identifiable as members of the megakaryocyte series, constituted 22.9% of the total fluorescein positive nucleated bone marrow cells. This antiserum was also used to label colonies cultured from human peripheral blood mononuclear cells using a modified plasma clot technique. A mean of 123 fluorescein-labeled colonies were cloned per 10(6) mononuclear cells cultured. Granulocyte-macrophage and erythroid burst colonies did not label using this method. No augmentation of colony numbers was found with varying concentrations of erythropoietin, human embryonic kidney cell conditioned media (a source of thrombopoietin), or media conditioned by a human T lymphoblast cell line (a source of both colony stimulating and burst promoting activities). Immunofluorescent labeling for platelet glycoproteins is a convenient phenotypic marker for cells of human megakaryocyte lineage useful in the study of in vitro human megakaryocytopoiesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7004535

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Kinetics of megakaryocyte progenitor cells in idiopathic thrombocytopenic purpura.

Authors:  K Dan; S Gomi; T Nomura
Journal:  Blut       Date:  1990-11

Review 2.  Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. An overview.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Expression of a surface antigen (MA6) by peripheral blood CD34+ cells is correlated with improved platelet engraftment and may explain delayed platelet engraftment following cord blood transplantation.

Authors:  Paul J Simmons; Simon N Robinson; Mark F Munsell; Michael W Thomas; Jeannie A Javni; Nathalie Brouard; Patrick A Zweidler-McKay; Elizabeth J Shpall
Journal:  Stem Cells Dev       Date:  2015-03-18       Impact factor: 3.272

4.  In situ immunocytochemical staining of cell colonies growing in plasma clot.

Authors:  A Bontadini; M Gobbi; A Dinota; P L Tazzari; M T Rivano; S Pileri
Journal:  Histochemistry       Date:  1988

5.  Studies of human megakaryocytopoiesis using an anti-megakaryocyte colony-stimulating factor antiserum.

Authors:  H H Yang; E Bruno; R Hoffman
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

6.  In vitro studies of human pluripotential hematopoietic progenitors in polycythemia vera. Direct evidence of stem cell involvement.

Authors:  R C Ash; R A Detrick; E D Zanjani
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

7.  Antigenic differences between human platelets and megakaryocytes.

Authors:  P Hyde; D Zucker-Franklin
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

8.  Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.

Authors:  P J Ballem; G M Segal; J R Stratton; T Gernsheimer; J W Adamson; S J Slichter
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

9.  Regulation of human megakaryocytopoiesis. An in vito analysis.

Authors:  E M Mazur; R Hoffman; E Bruno
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

10.  Megakaryoblastic micromegakaryocytic crisis in chronic myeloid leukemia.

Authors:  G Lingg; F Schmalzl; J Breton-Gorius; A Tabilio; H E Schaefer; D Geissler; M Schweiger; W Kirchmair
Journal:  Blut       Date:  1985-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.